Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2015/12/006429
CTRI/2015/12/006429Active, not recruitingPhase 4

A Prospective, Open Label, Parallel Group, Randomized Controlled clinical study toevaluate the effect of flavoured oats and blended oil with antioxidants in preâ??diabetes subjects - Nil

Spectrum Clinical Research Pvt Ltd0 sites0 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Phase 4
Status
Active, not recruiting
Sponsor
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •Subjects of either sex in the age group between 30 to 45 years
  • •Pre-diabetics
  • •Willingness to maintain current activity levels and follow the prescribed diet.
  • •Preferably non-smokers, non-alcoholic and non- tobacco users

Exclusion Criteria

  • •Recent history (past 12 months) of drug abuse or alcohol abuse
  • •Current smoker
  • •Women who are pregnant, lactating, or planning to become pregnant.
  • •Liver disorders.
  • •Congestive cardiac failure, acute myocardial infarction within last 1 month
  • •Subjects who are unlikely to comply with Protocol requirements e.g. uncooperative attitude, subjects who are frequent travelers, inability to return for follow up visits.

Investigators

Sponsor
Spectrum Clinical Research Pvt Ltd

Similar Trials

Completed
Phase 3
Phase III clinical trial for Evaluation of Efficacy and Safety of IN-ALRN-001 in Comparison with Tamsulosin in Patients with lower urinary tract symptoms associated with BPH.
CTRI/2009/091/000742Intas Pharmaceuticals Limited200
Completed
Phase 3
Clinical Trial for Evaluation of Efficacy and Safety of Fixed Dose Combination of Minoxidil + Finasteride Solution in Comparison with Minoxidil Solution in Adult Male Patients with Androgenic Alopecia
CTRI/2009/091/000896Intas Pharmaceuticals Limited270
Active, not recruiting
Not Applicable
A Randomized, Open Label, Parallel Group, International, Multicenter, Phase III Study of Oral ZD1839 (IRESSA®) Versus Intravenous Docetaxel (TAXOTERE®) in Patients With Locally Advanced or Metastatic Recurrent Non Small Cell Lung Cancer who have Previously Received Platinum Based Chemotherapy - INTERESTocally Advanced or Metastatic Recurrent Non-Small Cell Lung Cancer
EUCTR2004-002943-28-LVAstraZeneca AB1,440
Completed
Phase 3
A clinical trial to study the effects of two drugs, IN-ASTR-001 and fluoxetine in patients with major depression.
CTRI/2011/05/001719Intas Pharmaceuticals Limited280
Recruiting
Phase 4
A Study to Evaluate the Efficacy and Safety of fixed dose combination of Etoricoxib(60mg) and Thiocolchicoside (4mg) in patients with Low Back Pain.
CTRI/2022/07/043690MANKIND PHARMA LTD